3Takizawa H, Desaki M, Ohtoshi T, et al. Erythromycin supperlesses interleukin-6 expression by human bronchial epithelial cells:a potential mechanism of its anti-inflammatory action[J]. Biochem Biophys Res Commun, 1995,210( 3 ) : 781 - 786.
4Amsden GW. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of communityacquired respiratory tract infections and chronic inflammatory pulmonary conditions? [J]. J Antimicrob Chemother, 2005, 55(1):10- 21.
5Hatipoglu U, Rubinstein I. Low-dose, long-term macrolide therapy in asthma: an overview[J].Clin Mol Allergy, 2004, 2(1) :4.
6Wales D, Woodhead M. The anti-inflammatory effects of maerolides[J]. Thorax, 1999,54(2) : S58 - S62.
7Sharma S, Jaffe A, Dixon G. Immunomodulatory Effects of MacrolideAntibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis[J]. Paediatr Drugs,2007 9(2) :107 - 118.
8Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease[J]. Chest,2004,125(2) :70S- 78S.
9Kostadima E, Tsiodras S, Alexopoulos El, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma[J]. Eur Respir J ,2004,23(5) :714 - 717.
10Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma[J]. N Engl J Med,2006,354(15):1 589-1 600.
